PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited has announced the application for quotation of a significant number of new fully paid ordinary shares, totaling 433,216,275, which are set to be issued on April 15, 2024. This application indicates a notable move for PYC, potentially signaling growth and inviting investor interest in the biotechnology firm’s expanding market presence.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.
